Pertussis

Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine

Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Maternal Determinants of Infant Immunity to Pertussis

Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

Confirmatory Study of BK1310 in Healthy Infants

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

Establishing a Controlled Human Infection Model of Bordetella Pertussis

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

10-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

Pertussis Immunization During Pregnancy & HIV Infection

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Maternal Pertussis Wholecell Responses